Joseph S. McCracken, Director at LUMOS PHARMA, INC. (LUMO), bought 14,950 shares at $7.55 ($113K) on 2021-08-11, disclosed to the SEC on 2021-08-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.55 | 7,475 | $56K | 50.0% |
| 2 | $7.55 | 7,475 | $56K | 50.0% |
| Total | $7.55 avg | 14,950 | $113K | 100% |
| Filing → |
| LUMO | BUY | 2022-11-18 | $20K | — | Filing → |
| LUMO | BUY | 2022-08-26 | $27K | — | Filing → |
| SVRA | BUY | 2021-03-15 | $200K | — | Filing → |